You are offline. Saved alerts are still available. Live updates resume when you reconnect.
Reading a stock page
- The tabs show the price chart, results, shareholding, events and news for this one company.
- The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
- Every figure names its source. "Official" means it came from NSE or BSE filings.
- Use the star to watch the stock, or Add to portfolio to record a trade.
🎯 Buy It or Not? — Complete Intraday to Long-Term Decision Report for ZIMLAB (NSE)
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
89
ISA Signal Score: Strong setup
Trend100
Momentum100
52-week range96
Volume95
Risk48
Working for it
- Price is above its 20-day average
- Price is above its 50-day average
- Price is above its 200-day average (long-term uptrend)
- 50-day average is above the 200-day average
- 50-day average is rising
- RSI 60: healthy strength
At a glance
QualityNot knownNeeds the yearly results. They load from NSE on their own for NSE stocks.
GrowthNot knownNeeds the yearly results.
ValuationNot knownNeeds EPS from the yearly results.
MomentumStrongAbove its 200-day average, beat NIFTY 50 by 104.3 points
RiskHighSwings 50% a year, fell up to 24% from a peak, beta 0.62
Smart Investor Tips: ZIMLAB
Constructive Setup (Trend + Fundamentals Aligned)Actionable Insights & Positives
- Confirmed uptrend: trading above both rising 50-day (Rs 137.52) and 200-day (Rs 106.60) averages.
- Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.
Risk Checks & Things to Verify
- High 30-day annualized volatility (65%). Keep initial position sizes smaller and use wider stop-review levels.
NSE MCP Live & 5-Year Check No API Key
Algorithmic Buy / Sell Prediction & Optimal Entry PriceBUY / ACCUMULATE IN ZONE (Score 87/100)
Strong technical, volume & cash-flow setup. Best buy zone: Rs 135.46 – Rs 147.33 (Ideal entry ~Rs 141.40). Stagger 50% near Rs 147.33 and 50% near Rs 135.46. Stop-loss / review below Rs 96.68; Swing Target Rs 221.90 (R:R 1.8x).
| Optimal Buy Zone | Tranche 1 (50%) | Tranche 2 (50%) | Stop-Loss / Review | Target 1 (Swing) | Target 2 (Breakout) | Risk : Reward |
|---|---|---|---|---|---|---|
| Rs 135.46 – Rs 147.33 Ideal ~Rs 141.40 |
Rs 147.33 | Rs 135.46 | Rs 96.68 ATR 5.7% |
Rs 221.90 | Rs 275.56 | 1 : 1.8 RSI 61 · Vol 3.26x |
Live Candlestick & TradingView Chart (ZIMLAB)
MARKET CLOSED - EOD SNAPSHOTKey figures
P/E-price / earnings
P/B-price / book value
EPS-earnings per share
Dividend yield-from saved dividend events
Debt to equity-borrowings / equity
Sales growth-yearly, needs 2+ years
Profit growth-yearly, needs 2+ years
Operating margin-EBITDA / sales
About ZIM LABORATORIES
Pharma & HealthcareMarket capNot available
First listed25 Nov 2022BSE not available · NSE 25 Nov 2022
Face valueRs 10
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed
Profile completeness3 of 8Missing: description, share count, book value, ROE, ROCE
Shareholding
Promoters and group 30.30% -0.06 pp, public 69.70%, as on 30 Sep 2026. Holder names and history
Day range133.81 to 159.46Open 134.00
52-week high159.81
-6.9% from high (12 Oct 2026)
52-week low59.31
+150.9% from low (30 Mar 2026)
Volume15.50 L
18.2x the 20-day average
RSI (14)60
neutral
Volatility (30d)65.1%annualised
Returns
1W+5.5%
1M+7.7%
3M+23.0%
6M+48.7%
1Y+102.2%
YTD+106.3%
3Y a year+8.3%
Against the NIFTY 50
| Period | ZIMLAB | NIFTY 50 | Difference |
|---|---|---|---|
| 1M | +7.7% | +11.5% | -3.8 pts |
| 3M | +23.0% | +5.3% | +17.7 pts |
| 6M | +48.7% | +7.9% | +40.8 pts |
| 1Y | +102.2% | -2.1% | +104.3 pts |
Risk over the past year
Volatility50%high
Deepest fall-24.2%from a peak
Beta0.62moves less than the index
Best day+13.6%02 Sep 2026
Worst day-10.2%23 Mar 2026
Up days47%of sessions
Quarterly Results (Last 8 Quarters — QoQ & YoY Acceleration)
| Rs crore | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales / Revenue | 96.3 | 109 | 71.8 | 88.7 | 109 | 105 | 94.2 | 105 |
| Sales QoQ % | +4.5% | +12.9% | -34.0% | +23.6% | +22.5% | -3.1% | -10.5% | +12.0% |
| Operating Profit | 11.6 | 14.6 | 4.25 | 5.76 | 12.8 | 7.19 | 2.45 | 5.43 |
| Operating Margin (OPM %) | 12.0% | 13.4% | 5.9% | 6.5% | 11.8% | 6.8% | 2.6% | 5.1% |
| Net Profit (PAT) | 4.00 | 4.88 | -1.87 | -0.42 | 4.40 | 3.74 | -4.02 | -2.05 |
| Profit QoQ % | +68.1% | +22.0% | -138.3% | +77.5% | +1147.6% | -15.0% | -207.5% | +49.0% |
| Profit YoY % | -16.3% | -39.7% | -307.8% | -117.6% | +10.0% | -23.4% | -115.0% | -388.1% |
| Net Margin % | 4.2% | 4.5% | -2.6% | -0.5% | 4.0% | 3.6% | -4.3% | -1.9% |
Financials
Yearly results have not loaded yet.
Compared with its sector Pharma & Healthcare
| Stock | Price | Day | 1 year | Mkt cap (Cr) | P/E | P/B | ROE | Net margin |
|---|---|---|---|---|---|---|---|---|
| ALIVUSALIVUS LIFE SCIENCES LTD | 1,449.90 | +0.4% | - | 17,769 | 37.7 | 7.6 | 20.2% | 20.6% |
| AARTIPHARMAARTI PHARMALABS LIMITED | 1,024.60 | +1.1% | - | 9,285 | 42.8 | 5.3 | 12.3% | 11.7% |
| BLUEJETBLUE JET HEALTHCARE LTD | 516.85 | -0.3% | - | 8,965 | 54.8 | 10.6 | 19.4% | 23.0% |
| AARTIDRUGSAARTI DRUGS LTD. | 498.90 | -1.4% | - | 4,587 | 26.9 | 3.6 | 13.4% | 6.8% |
| DIVISLABDIVI S LABORATORIES LTD | 11,178.00 | +1.2% | - | - | - | - | - | - |
| WOCKPHARMAWOCKHARDT LIMITED | 2,187.00 | +7.9% | - | - | - | - | - | - |
| LAURUSLABSLAURUS LABS LIMITED | 2,306.00 | -0.7% | - | - | - | - | - | - |
| SUNPHARMASUN PHARMACEUTICAL IND L | 1,900.00 | +1.5% | - | - | - | - | - | - |
| MAXHEALTHMAX HEALTHCARE INS LTD | 1,040.65 | +1.7% | - | - | - | - | - | - |
| CIPLACIPLA LTD | 1,418.50 | +0.1% | - | - | - | - | - | - |
| APOLLOHOSPAPOLLO HOSPITALS ENTER. L | 8,738.00 | -0.9% | - | - | 64.7 | - | 21.1% | 7.9% |
| DRREDDYDR. REDDY S LABORATORIES | 1,400.90 | +0.2% | - | - | - | - | - | - |
| ZIMLABZIM LABORATORIES LIMITED | 148.82 | +9.9% | - | - | - | - | - | - |
| Sector median | - | 42.8 | 6.5 | 13.4% |
Today: 15 minute chart and signal
Analysis and next-session reading
Signals
Price is above its 50-day average
20-day average is below the 50-day (short-term downtrend)
Price is above its 200-day average (long-term uptrend)
RSI 60: neutral
Volume is 18.2x the 20-day average
When is a good price?
The price is in the upper quarter of its 1-year range and is lower than it was on 1% of days in the past year.
Support (prices below today's)
| 50-day average | 137.52 | -7.6% |
| 20-day low | 120.60 | -19.0% |
| 60-day low | 116.25 | -21.9% |
| 200-day average | 106.60 | -28.4% |
| 52-week low | 59.31 | -60.1% |
Resistance (prices above today's)
| 20-day high | 159.46 | +7.1% |
| 60-day high | 159.81 | +7.4% |
| 52-week high | 159.81 | +7.4% |
Zones buyers often watch
| Lower quarter of the 1-year range | 59.31 to 84.44 | Historically the cheapest part of the past year. |
| Pullback of 10% to 20% from the high | 127.85 to 143.83 | A common area for dips inside an uptrend. |
| Around the 200-day average | 103.41 to 109.80 | Long-term trend line, often watched as support. |
Moving averages and momentum
| Indicator | Value | Reading |
|---|---|---|
| 20-day average | 136.34 | Price is 9.2% above |
| 50-day average | 137.52 | Price is 8.2% above |
| 200-day average | 106.60 | Price is 39.6% above |
| RSI (14) | 60 | Neutral |
| MACD (12, 26, 9) | 1.17 | Above its signal line (momentum rising) |
| Volatility (30d) | 65.1% | High yearly swings |
Support and resistance
R2173.01
R1160.92
Pivot147.36
S1135.27
S2121.71
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| 2026-11-19 | 134.00 | 159.46 | 133.81 | 148.82 | +9.85% | 1,549,508 |
| 2026-11-18 | 137.08 | 138.97 | 133.57 | 135.47 | -0.38% | 13,103 |
| 2026-11-17 | 139.31 | 139.48 | 132.61 | 135.99 | -2.77% | 38,267 |
| 2026-11-16 | 142.30 | 142.30 | 138.98 | 139.87 | -0.72% | 26,626 |
| 2026-11-13 | 139.00 | 143.98 | 138.41 | 140.89 | -0.09% | 63,847 |
| 2026-11-12 | 136.68 | 143.45 | 134.75 | 141.02 | +4.72% | 108,587 |
| 2026-11-11 | 139.00 | 139.00 | 134.01 | 134.66 | -1.61% | 26,185 |
| 2026-11-09 | 137.40 | 138.00 | 132.00 | 136.86 | +1.74% | 46,083 |
| 2026-11-06 | 133.55 | 135.63 | 131.01 | 131.67 | -3.85% | 54,816 |
| 2026-11-05 | 137.00 | 144.20 | 135.10 | 136.94 | +1.87% | 235,319 |
| 2026-11-04 | 140.60 | 143.80 | 133.05 | 134.43 | -5.59% | 118,834 |
| 2026-11-03 | 133.05 | 144.00 | 133.05 | 142.39 | +5.65% | 59,920 |
| 2026-11-02 | 137.00 | 137.67 | 132.60 | 134.77 | -1.12% | 35,935 |
| 2026-10-30 | 134.63 | 137.89 | 130.00 | 136.29 | -0.18% | 77,430 |
| 2026-10-29 | 140.10 | 145.08 | 133.86 | 136.54 | -3.34% | 67,351 |
| 2026-10-28 | 130.35 | 143.29 | 130.01 | 141.26 | +5.56% | 124,344 |
| 2026-10-27 | 126.60 | 134.95 | 126.60 | 133.82 | +5.63% | 106,560 |
| 2026-10-26 | 125.20 | 129.13 | 120.60 | 126.69 | +0.37% | 92,596 |
| 2026-10-23 | 130.80 | 130.80 | 121.41 | 126.22 | -4.47% | 116,714 |
| 2026-10-22 | 130.63 | 134.43 | 130.63 | 132.12 | -0.13% | 73,408 |
| 2026-10-21 | 138.20 | 143.00 | 125.63 | 132.29 | -4.26% | 217,138 |
| 2026-10-19 | 145.60 | 146.57 | 135.81 | 138.17 | -4.55% | 63,229 |
News from the last 15 days More
Events
2026
- 04NovFinancial ResultRelease date · NSE record
- 06AugFinancial ResultRelease date · NSE record
- 19MayFinancial ResultRelease date · NSE record
- 11FebFinancial ResultRelease date · NSE record
- 21JanFund RaisingBoard meeting · NSE record
2025
- 12NovFinancial ResultRelease date · NSE record
- 07AugFinancial ResultRelease date · NSE record
- 20MayFinancial ResultRelease date · NSE record
- 10FebFinancial ResultRelease date · NSE record
2024
- 09NovFinancial ResultRelease date · NSE record
- 20JunAnnual General MeetingNSE record
2023
- 03JulAnnual General MeetingNSE record
2022
- 22DecBonusEx date · NSE record2:1Ratio